Information for ligand BLM
sdf, pdb, mol, mol2
Ligand Name: Bleomycin a2
Synonyms
| 1 | N(1)-[3-(dimethylsulfonio)propyl]bleomycinamide |
| 2 | Bleomycin |
| 3 | (betar)-n(alpha)-{[6-amino-2-((1s)-3-amino-1-{[(2s)-2,3-diamino-3-oxopropyl]amino}-3-oxopropyl)-5-methylpyrimidin-4-yl]carbonyl}-beta-{2-o-[3-o-(aminocarbonyl)-alpha-d-mannopyranosyl]-alpha-l-gulopyranosyloxy}-n-[(1r,2s,3s)-5-({(1s,2r)-1-[({2-[4-({[3-(dimethylsulfonio)propyl]amino}carbonyl)-2,4'-bi-1,3-thiazol-2'-yl]ethyl}amino)carbonyl]-2-hydroxypropyl}amino)-3-hydroxy-4-methyl-5-oxopentan-2-yl]-l-histidinamide |
| 4 | N1-[3-(dimethylsulfonio)-propyl]bleomycinamide |
Chemical Component Summary
| Formula | "C55 H85 N17 O21 S3" |
| Molecular Weight | 1416.560 |
| SMILES | C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)c1nc(nc(N)c1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]3O)c4c[nH]cn4)C(=O)NCCc5scc(n5)c6scc(n6)C(=O)NCCC[SH](C)C |
| InchI | InChI=1S/C55H85N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81,96H,7-13,15-16,56H2,1-6H3,(H2,57,76)(H2,59,82)(H2,60,88)(H,61,65)(H,62,84)(H,63,85)(H,66,87)(H,70,83)(H,71,86)(H2,58,69,72)/t21-,22+,23+,24-,25-,29-,30+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43-,53+,54-/m0/s1 |
| InChIkey | ZGCQRJQBETWECF-UAPAGMARSA-N |
| DrugBank Reference | DB00290 |
| ChEBI Reference | N/A |
| PubChem Reference | 6323238 |
| FDA approved drug | yes |
Reference